Events After the End of the Reporting Period

Temasek subscribes to capital increase and acquires approximately 3.6% of Bayer

In April 2018, the investment company Temasek, Singapore, subscribed to 31 million new shares of Bayer, corresponding to around 3.6% of the increased capital stock, for total gross proceeds of €3 billion. The proceeds from this capital increase were used to reduce the syndicated credit facility arranged for financing the planned acquisition of Monsanto by US$ 3.7 billion to US$46 billion.

In light of the planned acquisition of Monsanto, Bayer signed an agreement to sell further Crop Science businesses to BASF on April 24, 2018. The businesses being divested include in particular the global vegetable seeds business, certain seed treatments, the research platform for wheat hybrids and certain glyphosate-based herbicides in Europe. In addition, three research projects in the field of total herbicides and Bayer’s digital farming business will also be transferred. In return, Bayer will receive a back license for certain digital farming applications.

Leverkusen, April 26, 2018
Bayer Aktiengesellschaft

The Board of Management

Werner Baumann

Liam Condon

Johannes Dietsch

Dr. Hartmut Klusik

Kemal Malik

Wolfgang Nickl

Heiko Schipper

Dieter Weinand

Compare to Last Year